DISCOVER
hosting
Secure hosting
or Health Data
Hosting services,
at your convenience
Telemedicine Technologies provides at the provider’s convenience classic Secure Hosting or Health Data Hosting, in accordance with GDPR and European health data protection regulations.
The Health Data Hosting service is based on an Infrastructure including a Primary Site and a Secondary Site that are geographically distinct. The Primary Site is ISO 27001 certified.
This Infrastructure is provided by specialist companies selected by Telemedicine Technologies for their excellent performance.
The Infrastructure is equipped with a fire protection system.
The redundancy of the power systems allows a normal running of the infrastructure in case of a total power cut, without any interruption of the service.
At the client’s request, we can provide a mirror site that guarantees automatic and immediate copying of data, thus bypassing any blocking or hacking of data.
Data confidentiality
- Physical access to the website hosting Infrastructure is permitted for duly authorised personnel.
- Protection against attempted intrusion by unauthorised employees: Access is protected by armoured doors, badge readers, fingerprint analysers and human checks.
- A router/firewall device monitored by certified Telemedicine employees provides protection against unauthorised remote access.
- With the exception of specific contractual points, the hosted server software has a dedicated SSL certificate ensuring HTTPS encryption.
Savings
service
continuity
Daily saving of application data performed locally on the Primary Site and on the remote Secondary Site.
Service availability rate > 99.9%.
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
2 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
September 29, 2023
17-18 Oct 2023 Building on the success of its long-running US-based counterpart, the 6th Annual SCOPE Europe: Summit for Clinical Ops Executives is a two-day executive conference serving clinical innovation leaders, clin ops execs, digital leaders, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the […]
September 29, 2023
Biopharm International On Sept. 21, 2023, FDA released a new guidance on how the agency plans to utilize alternative tools to remotely evaluate drug manufacturing facilities identified in a marketing application. The application may be a new drug application, an abbreviated new drug application, a biologics license application, or a supplement to any of these […]
September 29, 2023
Applied Clinical Trials While many US-based biopharma start-ups are interested in conducting clinical trials in Europe, they are often unfamiliar with European legislation and regulations. Some of the biggest misconceptions are around start-up timelines. Typically, the time it takes to go from initial clinical trial application to delivering the first dose to a patient takes […]